Patents by Inventor William A. Hare

William A. Hare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Using Ryanodine Antagonists in Treating Neural Injury
    Publication number: 20140039019
    Abstract: The present invention provides a method of providing neuroprotection to a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on its nerve cells an effective amount of a ryanodine antagonist, e.g. dantrolene, to inhibit or prevent nerve cell injury or death.
    Type: Application
    Filed: October 7, 2013
    Publication date: February 6, 2014
    Applicant: ALLERGAN, INC.
    Inventors: Cun-Jian Dong, William A. Hare
  • Methods of using ryanodine antagonists in treating neural injury
    Patent number: 8557855
    Abstract: The present invention provides a method of providing neuroprotection to a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on its nerve cells an effective amount of a ryanodine antagonist, e.g. dantrolene, to inhibit or prevent nerve cell injury or death.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: October 15, 2013
    Assignee: Allergan, Inc.
    Inventors: Cun-Jian Dong, William A. Hare
  • Methods of using ryanodine antagonists in treating neural injury
    Publication number: 20040006124
    Abstract: The present invention provides a method of providing neuroprotection to a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on its nerve cells an effective amount of a ryanodine antagonist, e.g. dantrolene, to inhibit or prevent nerve cell injury or death.
    Type: Application
    Filed: July 3, 2002
    Publication date: January 8, 2004
    Applicant: Allergan, Inc.
    Inventors: Cun-Jian Dong, William A. Hare
  • Method and apparatus for determining electrical activity in the retinal nerve fiber layer using intrinsic birefringent properties of retinal ganglion cell axons
    Patent number: 5485229
    Abstract: Apparatus and method for measuring retinal function in discrete regions of a retina includes selecting a discrete region of a retina having ganglion cell axons extending therefrom and to an optic nerve head and directing a linearly polarized beam of light on a probe region of retinal nerve fibers proximate the optic nerve head. Thereafter the discrete region is stimulated with light. Apparatus is provided for detecting light reflected from the probe region, before, during and after stimulation for producing an electrical signal corresponding to the amount of shifted linearly polarized light as a function of time.
    Type: Grant
    Filed: May 24, 1994
    Date of Patent: January 16, 1996
    Assignee: Allergan, Inc.
    Inventor: William A. Hare